Sinha SC et al. |
Catalytic antibody route to the naturally occurring epothilones: total synthesis of epothilones A-F. |
2001 |
Chemistry |
pmid:11349910
|
Prantz K and Mulzer J |
Synthesis of (Z)-trisubstituted olefins by decarboxylative grob-type fragmentations: epothilone D, discodermolide, and peloruside A. |
2010 |
Chemistry |
pmid:19943284
|
Haydl AM and Breit B |
The Total Synthesis of Epothilone D as a Yardstick for Probing New Methodologies. |
2017 |
Chemistry |
pmid:27792853
|
Kuppens IE |
Current state of the art of new tubulin inhibitors in the clinic. |
2006 |
Curr Clin Pharmacol |
pmid:18666378
|
Kolman A |
Epothilone D (Kosan/Roche). |
2004 |
Curr Opin Investig Drugs |
pmid:15242255
|
Bakota L and Brandt R |
Tau Biology and Tau-Directed Therapies for Alzheimer's Disease. |
2016 |
Drugs |
pmid:26729186
|
Sang F et al. |
Epothilone D and its 9-Methyl analogues: combinatorial syntheses, conformation, and biological activities. |
2013 |
Eur J Med Chem |
pmid:23994325
|
Harrison M and Swanton C |
Epothilones and new analogues of the microtubule modulators in taxane-resistant disease. |
2008 |
Expert Opin Investig Drugs |
pmid:18363517
|
Kealey JT |
Creating polyketide diversity through genetic engineering. |
2003 |
Front. Biosci. |
pmid:12456305
|
Woods LM et al. |
Synthesis and Biological Evaluation of 7-Deoxy-Epothilone Analogues. |
2017 |
Int J Mol Sci |
pmid:28304361
|
Konner J et al. |
Phase I clinical, pharmacokinetic, and pharmacodynamic study of KOS-862 (Epothilone D) in patients with advanced solid tumors and lymphoma. |
2012 |
Invest New Drugs |
pmid:22072399
|
Monk JP et al. |
A phase 1 study of KOS-862 (Epothilone D) co-administered with carboplatin (Paraplatin®) in patients with advanced solid tumors. |
2012 |
Invest New Drugs |
pmid:21826439
|
Beer TM et al. |
Phase II study of KOS-862 in patients with metastatic androgen independent prostate cancer previously treated with docetaxel. |
2007 |
Invest New Drugs |
pmid:17618407
|
Bergstralh DT et al. |
A comparison of signaling activities induced by Taxol and desoxyepothilone B. |
2004 |
J Chemother |
pmid:15700849
|
Burrell RC et al. |
Synthesis of stable isotope-labeled epothilone D using a degradation-reconstruction approach. |
2015 |
J Labelled Comp Radiopharm |
pmid:26158758
|
Wang Z et al. |
Determination of desoxyepothilone B in nude mice plasma by liquid-liquid extraction and reversed-phase high-performance liquid chromatography. |
2006 |
J Pharm Biomed Anal |
pmid:16616824
|
Jumaa M et al. |
Kinetics and mechanism of degradation of epothilone-D: an experimental anticancer agent. |
2004 |
J Pharm Sci |
pmid:15459947
|
White JD et al. |
Total synthesis of epothilone B, epothilone D, and cis- and trans-9,10-dehydroepothilone D. |
2001 |
J. Am. Chem. Soc. |
pmid:11389619
|
Tang L et al. |
Generation of novel epothilone analogs with cytotoxic activity by biotransformation. |
2003 |
J. Antibiot. |
pmid:12670045
|
Nagano S et al. |
Crystal structures of epothilone D-bound, epothilone B-bound, and substrate-free forms of cytochrome P450epoK. |
2003 |
J. Biol. Chem. |
pmid:12933799
|